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Derivation of a clinical decision guide in the diagnosis of cervical facet 1 
joint pain  2 
Abstract 3 
Objective: To derive a clinical decision guide (CDG) to identify patients best 4 
suited for cervical diagnostic facet joint blocks. 5 
Design: Prospective cohort study. 6 
Setting: Interventional pain management centre. 7 
Participants: Consecutive patients with neck pain, referred to an interventional 8 
pain management centre were approached to participate. One hundred twenty-9 
five patients participated. 10 
Interventions: Subjects underwent a standardized testing protocol, performed 11 
by a physiotherapist, prior to receiving diagnostic facet joint blocks. All subjects 12 
received the reference standard diagnostic facet joint block protocol, namely 13 
controlled medial branch blocks (MBB). The physicians performing the MBB were 14 
blinded to the local anaesthetic used and the findings of the clinical tests.  15 
Main Outcome Measure(s): Multivariate regression analyses were performed in 16 
the derivation of the CDG’s. Sensitivity, specificity, positive and negative 17 
likelihood ratios, and 95% confidence intervals were calculated for the index tests 18 
and CDG’s.  19 
Results: A CDG involving the findings of the manual spinal examination (MSE), 20 
palpation for segmental tenderness (PST), and extension-rotation test (ER) 21 
demonstrated a specificity of 84% (95% CI: 77 - 90) and positive likelihood ratio 22 
of 4.94 (95% CI: 2.80 – 8.20). Sensitivity of the PST and MSE were 94% (95% 23 
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CI: 90 – 98) and 92% (95% CI: 88 – 97) respectively. Negative findings on the 24 
PST were associated with a negative likelihood ratio of 0.08 (95% CI: 0.03 – 25 
0.24).  26 
Conclusions: The MSE, PST, and ER may be useful tests in identifying patients 27 
suitable for diagnostic facet joint blocks. Further research is needed to validate 28 
the CDGs prior to their routine use in clinical practice.  29 
 30 
Key words: clinical decision rule, neck pain, facet joint, cervical spine, physical 31 
examination, sensitivity, specificity 32 
 33 
Abbreviations: 34 
NPRS - Numeric Pain Rating Scale 35 
ROM – Range of motion 36 
NDI – Neck Disability Index 37 
PCS – Pain Catastrophizing Scale 38 
GHQ-28 – General Health Questionnaire 28 39 
S-LANSS - self-report version of the Leeds Assessment of Neuropathic 40 
Symptoms and Signs pain scale 41 
ERT – Extension-rotation test 42 
MSE – Manual spinal examination 43 
PST – Palpation for segmental tenderness 44 
CI – Confidence interval 45 
LR+ - Positive likelihood ratio 46 
LR- - Negative likelihood ratio 47 
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 It is estimated that the facet joint is a source of nociception in 36%-67% of 48 
individuals with persistent neck pain.1-3 Patients, with persistently high levels of 49 
neck pain/disability for at least three months, who fail to respond to conservative 50 
pharmacological or rehabilitation interventions may undergo facet joint 51 
interventions.4 In the United States, between 1997 and 2006, facet joint 52 
interventions increased in clinical use by 624%,5 which is notable, because they 53 
are invasive procedures, associated with significant costs, and carry a small risk 54 
of adverse events to the patient.  55 
In many jurisdictions, where resources are limited, there are lengthy wait-56 
times for facet joint interventions. Diagnostic facet joint blocks are used to 57 
determine an individual’s suitability for an intervention. However those who fail to 58 
positively respond to the diagnostic blocks, magnify delays for those who are 59 
appropriate candidates. Determining candidacy for diagnostic facet joint blocks is 60 
typically clinician-driven. At present there is little evidence to suggest stand-alone 61 
patient history or clinical examination can predict the outcome of these 62 
procedures.6 Although controversial, clinical tests such as range of motion 63 
(ROM), segmental palpation (PST), the extension-rotation test (ERT), and 64 
manual spinal examination (MSE) are used as tools to assist clinicians assessing 65 
patients who may be suffering from cervical facet joint mediated pain.7-9 As with 66 
most clinical decision-making, no single test can reliably identify the facet joint as 67 
the source of pain. The derivation of a clinical decision guide (which pools 68 
findings from a cluster of clinical tests), may improve the accuracy of determining 69 
candidacy for diagnostic facet joint blocks.9  70 
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This study aimed to derive a clinical decision guide (CDG) from physical 71 
tests to identify which patients are best suited for diagnostic facet joint blocks. 72 
Since psychological factors may also have an influence on outcomes,10,11 73 
potential moderating variables were also examined. 74 
 75 
Methods 76 
Study Design 77 
A prospective cohort study conducted in a tertiary interventional pain 78 
management centre in Calgary, Alberta, Canada. Ethical approval was obtained 79 
from the Conjoint Health Research Ethics Board at the University of Calgary. 80 
  81 
Participants 82 
Data collection occurred between October 2011 and December 2012. 83 
Consecutive subjects with persistent neck pain, referred for diagnostic facet joint 84 
blocks were approached to participate. Subjects between the ages of 18-65 85 
years with reported neck pain intensity of ≥3/10 on a Numeric Pain Rating Scale 86 
(NPRS) for a minimum of 3 months were included.12 The value of ≥3/10 was 87 
selected to exceed the reported measurement error of the NPRS.13 Exclusion 88 
criteria were: cervical radiculopathy, upper motor neuron disease; neck pain 89 
related to systemic disease, infection, neoplasm, or fracture; a medically 90 
diagnosed psychological disorder; uncontrolled diabetes; uncontrolled clotting 91 
disorder; pregnancy; workers compensation claim or ongoing litigation.  92 
 93 
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Procedures 94 
Upon enrollment, subjects completed a demographic questionnaire and 95 
four standardized self-report measures. The Neck Disability Index (NDI), Pain 96 
Catastrophizing Scale (PCS), General Health Questionnaire–28 (GHQ-28), and 97 
the self-report version of the Leeds Assessment of Neuropathic Symptoms and 98 
Signs pain scale (S-LANSS) are reliable/valid measures for spine-related pain.13-99 
22
  100 
Two distinct clinician groups participated in the study. Physiotherapists 101 
performed the clinical examinations and an interventional radiologist, physiatrist, 102 
and radiology technician were responsible for the diagnostic facet joint blocks. 103 
Both groups were blinded to each other’s test results.  104 
 105 
Clinical examination 106 
One of four experienced physiotherapists with 10-25 years of clinical 107 
experience assessed subjects prior to the diagnostic blocks. To standardize the 108 
examinations, all physiotherapists received a training manual outlining the 109 
operational definitions of the clinical tests and a one-hour training session.  110 
The examination included cervical ROM testing, the ERT, MSE, and PST. 111 
Measurements of ROM into flexion, extension and side-flexion were made with a 112 
inclinometer.24 Rotation was measured using a dual-armed goniometer.24 113 
Thoracic movement was consciously minimized and subjects were asked to 114 
move their head and neck as far as possible. ROM was measured and subjects 115 
reported any pain on an NPRS, which was subsequently categorized as 116 
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‘increased’, ‘decreased’ or ‘no change’ in familiar pain. For the ERT, subjects 117 
were seated and asked to extend fully their head, followed by rotation to both 118 
sides. Subjects reported any pain at the end of motion. A positive test was 119 
defined as the provocation of familiar cervical spine pain intensity (≥3/10).   120 
MSE7,25 was performed to detect the presence or absence of cervical facet 121 
joint dysfunction.7,23 The subject was positioned prone with their cervical spine in 122 
a neutral position. The assessor applied a posterior-anterior directed force over 123 
the articular pillars from C2-3 to C6-7 on each side (diagnostic facet joint blocks 124 
were not performed for the C0-1 and C1-2 joints). Any perceived resistance to 125 
motion was categorized as ‘normal’, ‘slight’, ‘moderate’, or ‘marked’.23 The 126 
subject also reported any pain provocation on a NPRS; with a positive test 127 
defined as a report of familiar local or referred pain of ≥3/10 when the assessor 128 
rated ‘moderate’ or ‘marked’ resistance to motion.23  129 
PST was performed with the subject prone. The assessor palpated the 130 
segmental muscles overlying the facet joints, C2-3 to C6-7 bilaterally. These 131 
muscles have the same nerve supply as the painful joint and react with 132 
tenderness and spasm.24,25 The test was considered positive if the patient 133 
reported an increase in familiar pain, either local or referred, at an intensity of 134 
≥3/10.  135 
All tests have demonstrated moderate to excellent intra-rater and inter-136 
rater reliability in patients with axial neck pain referred for diagnostic facet joint 137 
blocks.26 Each testing session lasted approximately 15 minutes.  138 
 139 
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Reference standard diagnostic facet joint blocks: 140 
Comparative medial branch blocks (MBB) were performed as the 141 
reference standard for the diagnosis of facet joint pain for all subjects, which is 142 
the most widely internationally accepted approach.27,28 For this approach, the 143 
MBB is performed on two occasions with two different anaesthetics to reduce the 144 
high false positive rate associated with single block procedures.29,30 This 145 
procedure involved the injection of 0.5 ml of either Bupivacaine 0.5% or 146 
Lidocaine 2% under fluoroscopic guidance onto the sensory nerves (medial 147 
branch of the dorsal ramus and/or the third occipital nerve) of the target facet 148 
joint. Contrast material (0.25 ml of Omnipaque 300) was injected at each spinal 149 
level to ensure target specificity of the facet blocks. The anaesthetics were 150 
delivered in a random order to minimize measurement bias associated with the 151 
order of delivery of the anaethetics.28,31 The subjects and the interventional 152 
radiologist or physiatrist performing the block was blinded to the anaesthetic 153 
used. The interventional radiologist, physiatrist, and radiology technician were 154 
blinded to any study related pre-injection outcomes measures or clinical 155 
examination findings. The physicians performing the MBBs had 5-15 years of 156 
experience in these procedures. 157 
 All subjects underwent an initial MBB. A radiology technician recorded 158 
subjects’ neck pain intensity on an 11-point NPRS before and after the block. A 159 
positive response was defined as a ≥80% decrease in familiar neck pain intensity 160 
for at least the duration of the anaesthetic used (≥1 hour for Lidocaine and ≥3 161 
hours for Bupivacaine).32 Positive responders underwent a second MBB one 162 
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week following their initial block. A subject was deemed to have facet joint pain if 163 
they experienced a positive response to both MBB’s. For negative responders, if 164 
the physician performing the injection or the referring physician felt that another 165 
facet joint was the likely source of neck pain, the subject underwent another facet 166 
joint block at a neighboring spinal level.   167 
 168 
Data Analysis 169 
 The sample size was determined a priori based on the reported 170 
prevalence (36%-67%) of facet joint pain in the cervical spine.1-3 With 171 
conservative use of this data, we estimated the prevalence of facet joint pain in 172 
our sample to be 40%. In deriving a CDG from multivariable regression analyses, 173 
at least 10 outcome events (diagnosis of facet joint pain) should occur for each 174 
predictor variable.33,34 A priori, we determined that a CDG with more than five 175 
predictor variables may not be efficient for clinicians utilizing the guide in 176 
practice. From this, our study would require at least 50 positive outcome events 177 
(subjects diagnosed with facet joint pain). Given an anticipated prevalence of 178 
facet joint pain in our sample of 40% and the use of up to five predictor variables 179 
in the CDG, the number of subjects needed in our study was 125 (50/n = .40). 180 
 Descriptive statistics were used to summarize subjects’ baseline 181 
demographic data. Clinical measures were analyzed for their association with the 182 
outcome of diagnostic facet blocks via univariate and multivariate logistic 183 
regression. Clinical tests with acceptable levels of intra-rater and inter-rater 184 
reliability (kappa statistic ≥0.60 or intraclass correlation coefficient ≥0.80) were 185 
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considered in the development of the CDG.35 The outcome data from the clinical 186 
tests and diagnostic facet joint blocks were entered into contingency tables to 187 
calculate sensitivity, specificity, and likelihood ratios (LR+ and LR-) and 188 
subsequent confidence intervals associated with the CDG’s. Interpretation of the 189 
magnitude of the likelihood ratios followed the guide reported by Guyatt and 190 
colleagues.36  191 
The presence of effect modification by age, gender, catastrophization, and 192 
psychological distress was evaluated in multivariate logistic regression analyses. 193 
Confounding by age, gender, baseline neck pain and disability, catastrophization, 194 
and psychological distress was controlled for in the analyses. Receiver operating 195 
characteristic (ROC) curves for the statistically- and clinically-significant 196 
prediction models were constructed, along with their respective areas under 197 
curve (AUC). All statistical analyses were performed using STATA 11 (StataCorp 198 
LP, College Station, Texas. USA). 199 
 200 
Results 201 
Of the 177 individuals approached to participate in the study, 38 were 202 
excluded based on the inclusion/exclusion criteria, 14 declined participation, and 203 
125 consented to participate (Figure 1). There were no clinically relevant 204 
differences in age, gender, neck pain intensity, and duration of neck pain 205 
between participants (Table 1) and non-participants. The C5-6, C6-7, and C2-3 206 
facet joints were the most frequent joints to undergo diagnostic facet joint blocks, 207 
with a prevalence of 36%, 33%, and 23% respectively. Of the 125 subjects, 52 208 
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(42% pre-test probability/prevalence) had positive responses to the blocks. Of 209 
the positive responders, 14 were positive at C2-3; 12 were positive at C3-4; four 210 
were positive at C4-5; 21 were positive at C5-6; and 11 were positive at C6-7, 211 
and 10 were positive at two levels (i.e., C2-3 and C3-4). There were no adverse 212 
events associated with the index tests or reference standard. 213 
From the statistically significant univariate logistic regression analyses, the 214 
most robust odds ratios were found with PST, followed by MSE and the ERT 215 
(Table 2). In all three analyses 95% confidence intervals were wide. Table 3 216 
outlines the contingency tables comparing the clinical test findings with the 217 
outcome of the diagnostic facet joint blocks. In all circumstances, a higher 218 
percentage of true positives and true negatives occurred with each single or 219 
combinations of test findings. If a subject tested positive on all three clinical tests, 220 
the LR+ was 4.94 (95%CI: 2.80–8.20) and the post-test probability of a diagnosis 221 
of facet joint pain increased from 42% to 78%. Conversely, if a subject tested 222 
negative on PST, the LR- was 0.08 (95%CI: 0.03–0.24) and the post-test 223 
probability of a diagnosis of facet joint pain decreased to 5% (Table 4). 224 
In analyzing the results of the multivariate logistic regression analysis, 225 
because of high agreement between MSE and PST, collinearity was evident in 226 
the model (Table 5).37 As a result, multivariate logistic regression analyses were 227 
performed for two separate models with one containing the predictor variable 228 
PST, and the other containing the MSE. The multivariate model, controlling for 229 
age, gender, catastrophization, baseline neck pain and disability, and 230 
psychological distress, examining the association between PST and the ERT and 231 
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the outcome of the diagnostic facet joint blocks revealed no evidence of effect 232 
modification or confounding. For this model, ROC analysis resulted in an AUC of 233 
0.90 and a sensitivity and specificity of 89% and 84% respectively. There was 234 
also no evidence of effect modification or confounding for the regression model 235 
that included MSE and the ERT. For this model, the AUC determined from ROC 236 
analysis was 0.89 and the sensitivity and specificity was 87% and 82% 237 
respectively. 238 
 239 
Discussion 240 
  This study is the first to derive a CDG, incorporating the findings from a 241 
cluster of clinical tests, with utility to predict a diagnosis of cervical facet joint 242 
mediated pain. Our findings indicate that a positive stand-alone finding on the 243 
extension-rotation test lacks the diagnostic accuracy to rule-in facet joint 244 
mediated pain, and suggests a similar conclusion for MSE and PST when used 245 
in isolation. In contrast, our results showed that the MSE and PST exhibit high 246 
sensitivity and low LR-, used as a stand-alone finding or in combination, which 247 
supports their use as potential screening tests prior to referring a patient for facet 248 
joint blocks. Our data indicated that the lowest LR- was associated with the PST 249 
test (CDG 2). Subsequently, if a patient tests negative on the PST test, this 250 
provides clinicians with a large and notable shift in probability that the patient 251 
does not have facet joint mediated pain.36,38  252 
These CDGs require validation, as the clinical implications of our findings 253 
may have a positive influence on practice. In a large sample of Medicare 254 
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patients, Manchikanti et al.39 reported that 317, 220 cervical/thoracic facet joint 255 
blocks were performed in 2011 (a 359% increase from the year 2000).Thus, the 256 
use of effective screening procedures to determine candidacy for facet joint 257 
blocks could eliminate a substantial number of inappropriate procedures with 258 
significant cost savings. When a patient tests positive on the MSE, PST, and 259 
ERT, or combination of either MSE/ERT or PST/ERT (CDGs 5-7) the magnitude 260 
of the LR+ associated with the CDGs provides clinicians with a small/moderate 261 
shift in probability that the patient has facet joint mediated pain.36,38 If our findings 262 
are transferable to clinical practice, a positive cluster of MSE, PST and ERT 263 
would improve the likelihood of targeting facet joint blocks to the proper 264 
candidates.  265 
In clinical practice, multiple factors often influence decision-making and 266 
outcomes. Thus, we performed a multivariate analysis, with control for 267 
covariates, to reflect these outside contributions. Two models (one consisting of 268 
the MSE and the ERT and the other involving PST and the ERT) possessed 269 
good diagnostic accuracy, whether adjusted or unadjusted, and discriminative 270 
validity (as reflected by the AUC from the ROC analysis). However, the use of 271 
multivariate modeling that address covariates which potentially influence 272 
outcomes for clinical decision-making is a complex venture; with most clinicians 273 
lacking statistical knowledge, technology, and ability to run analyses for informed 274 
management of their patients with neck pain. Sensible CDGs must be 275 
uncomplicated to use and should have the capacity to change clinician 276 
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behaviour.40,41 The MSE and PST tests are both relatively simple to use, clinically 277 
relevant, and the standardized testing protocol is efficient.  278 
The assessment process used in this study requires explicitly applied 279 
movements to the joints and muscular tissue of the neck and has been 280 
historically used to assess patients with suspicion of cervical facet joint pain.8,10,11 281 
Tests such as the MSE and PST, aim to identify specific dysfunctional spinal 282 
motion segments, either through identification of resistance, or reproduction of 283 
pain at a given segment. It has been hypothesized that pain thresholds and tonic 284 
guarding associated with muscular stiffness are notably altered in those with 285 
cervical facet joint pain.42 The cervical facet joint capsules possess free 286 
(nociceptive) nerve endings, mechanoreceptors, A-delta and C-fibres.43,44 The 287 
cervical facet joints and the deep segmental muscles are innervated by the 288 
medial branch of the dorsal rami.25 As a result, the tensile forces applied to the 289 
facet joint (capsule) and surrounding muscular tissue may explain the possible 290 
relationship that exists between results of the manually-oriented physical 291 
examination and the results of diagnostic facet joint blocks. Recent evidence 292 
suggests that cervical facet joint blocks have a short-term anaesthetic effect and 293 
a hypoalgesic benefit to mechanical stimuli at surrounding cervical muscular 294 
tissue.45,46 At best we can only speculate the potential overlap of response 295 
mechanisms as, to our knowledge, no study has evaluated the physiological 296 
effects of the manually-oriented physical examination and facet joint blocks in a 297 
single trial. 298 
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Two prior studies have used a similar MSE methodology and have 299 
reported contradictory results. A landmark study by Jull et al.7 examined the 300 
ability of an experienced physiotherapist to identify symptomatic facet joints in 20 301 
patients with neck pain undergoing a single facet joint block. Remarkably, the 302 
manual spinal examination used in their study was 100% sensitive and 100% 303 
specific in deciphering those with and without facet joint pain. In our study, we 304 
incorporated a similar MSE procedure, but we compared our index test findings 305 
against those of the currently accepted reference standard, comparative, 306 
controlled MBBs, for the diagnosis of facet joint pain.27 Single diagnostic blocks 307 
provide high false positive rates ranging from 27% to 63%.29,30 This finding 308 
challenges the magnitude of the sensitivity and specificity noted by Jull et al.7, 309 
and may explain some of the discrepancies between our findings.  310 
King et al. questioned the value of the MSE. Using comparative, controlled 311 
MBBs as the reference standard, King et al.6 reported a sensitivity of 89% 312 
(95%CI: 82%-96%), specificity of 47% (95%CI: 37%-57%), and a LR+ of 1.7 313 
(95%CI: 1.2–2.5). In their study, only patients with positive results on the MSE 314 
underwent the criterion standard facet joint blocks. As a result, measurement 315 
bias (verification bias) may explain the differences between our study results.36 316 
This form of bias may have lead to an underestimate of the specificity of the MSE 317 
noted in their study.47  318 
Using electronic pressure algometry for the assessment of muscular pain 319 
sensitivity over the facet joints in a small number of patients with neck pain, 320 
Seigenthaler et al.48 challenged the diagnostic accuracy of the PST due to the 321 
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low sensitivity (13%) found in their study. Although their assessment methods 322 
were sophisticated, one needs to be cautious when interpreting their findings, as 323 
their study sample was small and not powered to determine diagnostic accuracy 324 
statistics. 325 
 326 
Study Limitations   327 
 Our assessors were experienced physiotherapists, thus the findings may 328 
not necessarily be generalizable to all clinicians. The subjects had diagnostic 329 
facet joint blocks to the putatively painful joints based on their pain pattern and 330 
response to the previous facet joint blocks, and did not receive facet blocks at 331 
every spinal level in the neck. Nonetheless, by having every subject undergo the 332 
reference standard, we believe that we minimized diagnostic work-up bias.47 The 333 
subjects duration of symptoms was highly variable, which may have influenced 334 
our results. Importantly, our study sample is representative of patients referred 335 
for diagnostics facet joint injections, facilitating the clinical utility of our findings.4 336 
We chose clinical tests that have either been studied previously for their 337 
diagnostic accuracy for cervical facet joint pain or have been widely used by 338 
clinicians based on the assumption of the test’s ability to provoke facet joint pain. 339 
There may be other potentially useful clinical tests. For example, a lateral gliding 340 
technique and MSE have been validated against dynamic radiographic 341 
examination to detect cervical joint hypomobility (rather than necessarily the 342 
symptomatic segment).49,50 These clinical tests are similar to those used in our 343 
study and it may be of interest to evaluate their utility in future studies validating 344 
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our CDG. Our study involved the derivation of a potentially useful CDG. 345 
Validation studies and impact analyses are needed prior to the routine use of our 346 
CDG in clinical practice. 347 
 348 
Conclusions 349 
This study identified derived CDGs that have clinical sensibility, are easy to 350 
implement in clinical practice, and once validated, may augment decision-making 351 
when contemplating referral for facet joint blocks. Our initial findings suggest that 352 
negative findings on the MSE and/or PST may inform clinicians that facet joint 353 
blocks may not be an optimal procedure for their patients with persistent neck 354 
pain. 355 
356 
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Figure 1: Flow diagram of subject recruitment and participation 511 
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Table 1: Baseline Demographics 
 
 Median (Range) 
N = 125 
Age (years) 
 
49 (21 - 65) 
Gender 
 
84 females, 41 males 
Baseline neck pain intensity (NPRS 0-10) 
 
6 (3 - 9) 
 
Subjects (%) with baseline neck pain intensity ≥ 
5/10  
 
82 
Onset of pain (%) 
     Traumatic 
     Gradual 
     Sudden 
 
 
47 
46 
7 
 
Motor vehicle collision (%)(n=53) 
     Frontal impact 
     Side impact 
     Rear impact 
 
 
15 
26 
59 
Smoker (%) 
 
22 
Employed (%) 
     Currently employed 
     On leave due to neck problem 
     Unemployed 
     Retired 
     Student 
 
 
63 
10 
11 
11 
5 
Duration of neck pain (months) 
 
18 (3 - 216) 
Neck Disability Index (0-50) 
 
20 (3 - 38) 
Subjects (%) with Neck Disability Index scores ≥ 
15/50 (self-reported moderate-severe neck pain 
and disability) 
 
74 
Pain Catastrophizing Scale (0-52) 
 
13 (0 - 44) 
General Health Questionnaire – 28 (0-84) 
 
22 (8 - 65) 
S-LANSS (0-24) 8 (0 - 19) 
 
Abbreviations: S-LANSS = self-report version of the Leeds Assessment of Neuropathic 
Symptoms and Signs pain scale 
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Table 2: Odds Ratios of the clinical variables in univariate logistic 
regression for predicting cervical facet joint pain 
 
 
Abbreviations: CI = confidence interval 
Clinical Variable Coefficient Standard Error Odds Ratio (95% CI) 
Extension-rotation 
test 
 
1.92 0.44 6.85 (2.91 – 16.13) 
Manual spinal 
examination 
 
3.39 0.58 29.71 (9.51 – 92.81) 
Palpation for 
segmental 
tenderness 
3.77 0.65 43.28 (12.11 – 154.77) 
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Table 3: Contingency tables comparing the clinical test findings with the 
outcome of the diagnostic facet joint blocks 
 
                                Diagnostic facet joint block 
 
MSE Positive Negative Total 
Positive 48 21  69 
Negative 4  52 56 
Total 52 73 125 
 
PST    
Positive 49 20  69 
Negative 3  53 56 
Total 52 73 125 
    
ERT    
Positive 43 30  73 
Negative 9  43 52 
Total 52 73 125 
    
MSE and PST    
Positive 48 18  66 
Negative 4  55 59 
Total 52 73 125 
   
MSE and ERT    
Positive 41 14 55 
Negative 11 59 70 
Total 52 73 125 
    
PST and ERT    
Positive 41 13 54 
Negative 11 60 71 
Total 52 73 125 
    
MSE/PST/ERT    
Positive 41 12  53 
Negative 11  61 72 
Total 52 73 125 
 
Abbreviations: MSE = manual spinal examination, PST = palpation for segmental 
tenderness, ERT = extension-rotation test 
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Table 4: Accuracy statistics with 95% confidence intervals for the clinical decision guides 
 
Clinical Decision 
Guide 
Sensitivity* (95% CI) Specificity* (95% CI) Positive Likelihood 
Ratio 
(95% CI) 
Negative Likelihood 
Ratio 
(95% CI) 
CDG 1: MSE 
 
92 (88 – 97) 71 (63 – 79) 3.17 (2.22 – 4.64) 0.11 (0.04 – 0.28) 
CDG 2: PST 
 
94 (90 – 98) 73 (65 – 80) 3.48 (2.35 – 5.03) 0.08 (0.03 – 0.24) 
CDG 3: ERT 
 
83 (76 – 89) 59 (50 – 68) 2.02 (1.49 – 2.72) 0.29 (0.16 – 0.54) 
CDG 4: MSE and PST 
 
92 (88 – 97) 75 (68 – 83) 3.74 (2.49 – 5.63) 0.10 (0.04 – 0.26) 
CDG 5: MSE and ERT 75 (67 – 82) 84 (78 – 91) 4.69 (2.51 – 6.72) 0.30 (0.15 – 0.45) 
     
CDG 6: PST and ERT 76 (68 – 83) 84 (78 – 91) 4.75 (2.65 – 7.39) 0.29 (0.15 – 0.44) 
     
CDG 7: MSE, PST,     
and ERT 
79 (72 – 86) 84 (77 – 90) 4.94 (2.80 – 8.20) 0.25 (0.15 – 0.43) 
 
Abbreviations: CDG = clinical decision guide, MSE = manual spinal examination, PST = palpation for segmental 
tenderness, ERT = extension-rotation test, CI = confidence interval 
* = proportions are stated as a percentage (%) 
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Table 5: Contingency table of frequency of test findings for the manual 
spinal examination and palpation for segmental tenderness 
 
                                                      PST 
MSE Positive Negative Total 
Positive 66* 3  69 
Negative 3  53* 56 
Total 69 56 125 
 
Abbreviations: MSE = manual spinal examination, PST = palpation for segmental 
tenderness, * = high levels of agreement between the two clinical tests 
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Figure 1: Flow diagram of subject recruitment and participation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excluded patients 
 n = 38 
1 
Consented to 
participate 
n = 125 
Declined to 
participate n = 14 
Received reference 
standard comparative 
medial branch blocks 
n = 125 
Participated in all index 
tests n = 125 
Positive outcome 
n = 52 
Eligible 
patients 
n = 177 
 
> 65 years (n = 19) 
Language barrier (n = 4) 
Already had injection (n = 4) 
Radiculopathy (n = 2) 
Could not cease anticoagulant 
therapy (n = 2) 
Pain intensity < 3 (n = 6) 
Did not have transportation  
(n = 1)  
Negative outcome 
n = 73 
